Hydrocortisone reduces mortality in severe community-acquired pneumonia
1. Among patients with severe community-acquired pneumonia (CAP) admitted to the intensive care unit (ICU), hydrocortisone reduced the risk of ...
1. Among patients with severe community-acquired pneumonia (CAP) admitted to the intensive care unit (ICU), hydrocortisone reduced the risk of ...
1. In a systematic review and meta-analysis, shorter courses of antibiotics were non-inferior in terms of treatment failure and treatment ...
1. In a systematic review and meta-analysis, shorter courses of antibiotics were non-inferior in terms of treatment failure and treatment relapse ...
1. New-onset atrial fibrillation following hospitalization for community acquired pneumonia was associated with higher subsequent thromboembolic risk. Evidence Rating Level: ...
1. Low-dose outpatient oral amoxicillin was noninferior to high-dose, and 3-day duration was noninferior to 7 days in children with ...
In this secondary analysis of a randomized, controlled trial, 26.8% of community-acquired pneumonia patients who received 3 days of antibiotics ...
1. In this secondary analysis of a randomized, controlled trial, 26.8% of community-acquired pneumonia patients who received 3 days of ...
1. Cure at 15 days occurred in 77% of patients in the placebo (3-day therapy) group compared to 68% of ...
1. Five-day treatment of community-acquired pneumonia in children was comparable to standard, 10-day treatment. Evidence Rating Level: 2 (Good) Community-acquired pneumonia ...
1. Among children with community-acquired pneumonia, proadrenomedullin more accurately predicted severe disease than established biomarkers such as C-reactive protein and ...
2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.
No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.
© 2021 2 Minute Medicine, Inc. - Physician-written medical news.